Seminars

Launched in September of 2005, the ITMAT monthly seminar series enters its fourth year. Outstanding role models who pursue translational research, from outside of the Penn community, are invited to lecture in this series, which is being coordinated by Dan Rader, MD.

Speakers, who represent excellence in translational medicine and therapeutics are asked to spend a day as an ITMAT Visiting Professor. In addition to their scientific presentation, they are scheduled to meet with faculty and have an informal session with trainees focused on career development.

Seminar presentations are scheduled once a month, at 1:00 PM on a Friday and take place in room the Smilow Center for Translational Research (SCTR) Auditorium.

 

Institute for Translational Medicine and Therapeutics Seminars

ITMAT Scholars Seminar

  • September 13, 2013

    Cross-talk & developmental programs – a key to translational stem cell biology
    Evan Snyder, M.D., Ph.D.
    Sanford-Burnham Medical Research Institute
  • October 18, 2013 {RESCHEDULED FOR SPRING 2014}

    Immunological mechanisms of fibrosis
    Thomas Wynn, Ph.D.
    National Institue of Allergy and Infectious Disease (NIH)
  • November, 13, 2013 (Special ITMAT/IDOM Seminar)
    John Morgan Building, Class of '62 Aud. (12pm)

    Towards a Comprehensive Understanding of Metabolism
    Prof. Joshua Rabinowitz
    Univeristy of Pennsylvania
  • November, 22, 2013 (12pm)

    Hematopoietic Stem Cell Niche
    David Scadden, M.D.
    Harvard University
  • December 13, 2013

    Translational Therapies for Canavan Disease
    Paola Leone, Ph.D.
    Rowan School of Medicine
  • January 24, 2014 (BRB II/III Aud)

    Protien O-glycosylation-Biological functions and diseases
    Prof. Henrik Clausen
    University of Copenhagen
  • February 21, 2014

    Opportunities for translational medicine in the stem cell niche, sickle cell disease, and beyond
    Paul Frennette, M.D.
    Yeshiva University
  • March 14, 2014

    Transcriptional control of innate lymphocyte effector programs
    Albert Bendelac, M.D., Ph.D.
    University of Chicago
  • April 11, 2014

    Immunological mechanisms of fibrosis
    Thomas Wynn, Ph.D.
    National Institue of Allergy and Infectious Disease (NIH)

 

Targeted Therapeutics Seminar Series

    Seminar presentations are scheduled once a month, at 12:00 PM on a Wednesday and take place in room the Smilow Center for Translational Research (SCTR) Auditorium, unless otherwise noted.

  • September 25, 2013

    In Vivo RNAi and Functional Genomics
    Victor Kotelianski,M.D., Ph.D
    Massachusetts Institute of Technology & Alnylam Pharmaceuticals

  • October 23, 2013

    Advanced Nanotechnologies addressing Intractable Medical Issue
    Gregory Lanza, M.D., Ph.D
    Washington University

  • November 6, 2013

    Preclinical studies for improving hemophilia treatment: gene therapy and immunomodulation
    Carol Miao, Ph.D
    University of Washington
  • December 4, 2013

    Nanotechnologies for Intracellular Delivery of Regenerative Biotherapeutics
    Craig Duvall, Ph.D.
    Vanderbilt University
  • January 29, 2014

    The Art of Falling Apart: Exploiting Nanomaterial Disassembly for Health Sciences
    Adah Almutairi, Ph.D.
    University of California, San Diego
  • February 19, 2014 [CANCELED-Reschedule date TBA]

    Reborn Approaches to Increase Drug Penetration into Tumors
    Francis Szoka, Ph.D.
    University of California, San Francisco

  • March 19, 2014

    Engineering approaches for enhanced vaccines and cancer immunotherapy
    Darrel Irviwn, Ph.D.
    Massachusetts Institute of Technology
  • April 16, 2014

    Switchable Nanoparticle Morphology as Tool in Tissue Targeting
    Nathan Gianneschi, Ph.D.
    University of California, San Diego
  • May 21, 2014

    Specific immunotherapy of undruggable cancer targets
    David Scheinberg, M.D., Ph.D.
    Memorial Sloan Kettering Cancer Center

» Top